{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-23-000030","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.878928+00:00","generated_at":"2026-06-16T01:32:41.664809+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sotera Health Q1 2023 revenue falls 7% to $221M; net income drops to $3M; reaffirms 2023 outlook","bullets":["Net revenues $221M, down 6.8% YoY; constant currency down 5.3%, driven by Nordion Cobalt-60 harvest timing.","Net income $3M ($0.01 diluted EPS) vs $31M ($0.11) in Q1 2022; Adjusted EPS $0.13 vs $0.22.","Adjusted EBITDA $98M, down 14.6% from $115M; total debt $2.3B, net leverage 3.4x.","Company reaffirms 2023 outlook despite Q1 declines attributed to expected Nordion harvest schedule timing."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-23-000030","json":"https://secwatch.observer/filing/0001822479-23-000030.json","markdown":"https://secwatch.observer/filing/0001822479-23-000030.md","text":"https://secwatch.observer/filing/0001822479-23-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247923000030/0001822479-23-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247923000030/shc-20230503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T01:32:41.664809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d97ad293749b29ee44955b07731b3ccfe3ba947b","claim":"Sotera Health Co reported the quarter ended March 31, 2023 results: revenue $221 million, net income $3 million, EPS $0.01 per diluted share. Guidance reaffirmed.","evidence_excerpt":"First-quarter 2023 net revenues decreased 6.8% to $221 million, compared with $237 million in the first-quarter 2022. Net revenues decreased 5.3% on a constant currency basis. Net income (“net income”) was $3 million, or $0.01 per diluted share, compared with net income of $31 million, or $0.11 per diluted share in the first-quarter 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822479/000182247923000030/0001822479-23-000030-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$221 million"},{"label":"Net income","value":"$3 million"},{"label":"EPS","value":"$0.01 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}